8-K//Current report
Aspire Biopharma Holdings, Inc. 8-K
Accession 0001493152-25-020891
$ASBPCIK 0001847345operating
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:50 PM ET
Size
264.8 KB
Accession
0001493152-25-020891
Documents
- 8-Kform8-k.htmPrimary
8-K
- EX-101.SCHasbp-20251104.xsd
XBRL SCHEMA FILE
- EX-101.DEFasbp-20251104_def.xml
XBRL DEFINITION FILE
- EX-101.LABasbp-20251104_lab.xml
XBRL LABEL FILE
- EX-101.PREasbp-20251104_pre.xml
XBRL PRESENTATION FILE
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- ZIP0001493152-25-020891-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLform8-k_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
Issuer
Aspire Biopharma Holdings, Inc.
CIK 0001847345
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001847345
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 4:50 PM ET
- Size
- 264.8 KB